Hemab Therapeutics Holdings, Inc.
COAG
$54.94
$0.991.84%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/9/2026
-
MarketBeat
8/13/2026
-
PR Newswire
8/13/2026
-
MarketBeat
8/12/2026
-
The Cerbat Gem
8/12/2026
-
MarketBeat
8/12/2026
-
TipRanks
8/12/2026
-
MarketBeat
8/11/2026
-
MarketBeat
8/6/2026
-
The Cerbat Gem
8/6/2026
-
MarketBeat
8/3/2026
-
MarketBeat
7/20/2026
-
MarketBeat
7/18/2026
-
MarketBeat
7/17/2026
-
MarketBeat
7/15/2026
-
MarketBeat
7/15/2026
-
MarketBeat
7/14/2026
-
Globe Newswire
7/13/2026
-
TipRanks
7/13/2026
-
MarketBeat
7/13/2026
-
MarketBeat
7/13/2026
-
The Cerbat Gem
7/13/2026
-
MarketBeat
7/12/2026
-
Globe Newswire
6/30/2026
-
TipRanks
6/26/2026
-
Morningstar
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, August 11, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of May 17 and 21 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(617) 553-3952
Address
101 Main Street
Suite 1220
Cambridge, MA 02142
Suite 1220
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human...
more